본문 바로가기
KERD
논문KCI 등재

Effects of Tamsulosin on Urinary Bladder Function and Neuronal Activity in the Voiding Centers of Rats with Cyclophosphamide-induced Overactive Bladder

2

조회

0

다운로드

14

인용

0

참고문헌

키워드

초록

Purpose: The overactive bladder (OAB) syndrome is characterized by urgency usually with frequency and nocturia. Tamsulosin, α1-adrenergic receptor antagonist, is widely used to reduce symptoms of urinary obstruction and prostatic hyperplasia. Tamsulosin can across the blood-brain barrier. We investigated the effects of tamsulosin on the symptoms of OAB in relation to neuronal activity using rats. Methods: Adult female Sprague-Dawley rats, weighing 250±10 g (9 weeks old), were used in this study. The animals were divided into five groups (n=8 in each group): control group, OAB-induced group, OAB-induced and 0.01 mg/kg tamsulosin-treated group, OAB-induced and 0.1 mg/kg tamsulosin-treated group, and OAB-induced and 1 mg/kg tamsulosin-treated group. OAB was induced by intraperitoneal injection of cyclophosphamide (75 mg/kg) every third day for 10 days. The rats in the tamsulosin-treated groups orally received tamsulosin once a day for 14 consecutive days at the respective dose of the groups, starting 1 day after the induction of OAB. Cystometry for bladder pressure determination, immunohistochemistry for c-Fos, nicotinamide adenine dinucleotide phosphate-diaphorase histochemistry for nitric oxide synthase (NOS) in the neuronal voiding centers and western blot for inducible NOS in the bladder were conducted. Results: Cyclophosphamide injection enhanced contraction pressure and time, representing the induction of OAB. Contraction pressure and time were significantly suppressed by tamsulosin treatment. c-Fos and NOS expressions in the neuronal voiding centers were enhanced by induction of OAB. OAB-induced c-Fos and NOS expressions were suppressed by tamsulosin treatment. Conclusions: Tamsulosin exerts inhibitory effect on neuronal activation in the neuronal voiding centers of OAB. The present results suggest the possibility that tamsulosin is effective therapeutic modality for ameliorating the symptoms of OAB.

Abstract

Purpose: The overactive bladder (OAB) syndrome is characterized by urgency usually with frequency and nocturia. Tamsulosin, α1-adrenergic receptor antagonist, is widely used to reduce symptoms of urinary obstruction and prostatic hyperplasia. Tamsulosin can across the blood-brain barrier. We investigated the effects of tamsulosin on the symptoms of OAB in relation to neuronal activity using rats. Methods: Adult female Sprague-Dawley rats, weighing 250±10 g (9 weeks old), were used in this study. The animals were divided into five groups (n=8 in each group): control group, OAB-induced group, OAB-induced and 0.01 mg/kg tamsulosin-treated group, OAB-induced and 0.1 mg/kg tamsulosin-treated group, and OAB-induced and 1 mg/kg tamsulosin-treated group. OAB was induced by intraperitoneal injection of cyclophosphamide (75 mg/kg) every third day for 10 days. The rats in the tamsulosin-treated groups orally received tamsulosin once a day for 14 consecutive days at the respective dose of the groups, starting 1 day after the induction of OAB. Cystometry for bladder pressure determination, immunohistochemistry for c-Fos, nicotinamide adenine dinucleotide phosphate-diaphorase histochemistry for nitric oxide synthase (NOS) in the neuronal voiding centers and western blot for inducible NOS in the bladder were conducted. Results: Cyclophosphamide injection enhanced contraction pressure and time, representing the induction of OAB. Contraction pressure and time were significantly suppressed by tamsulosin treatment. c-Fos and NOS expressions in the neuronal voiding centers were enhanced by induction of OAB. OAB-induced c-Fos and NOS expressions were suppressed by tamsulosin treatment. Conclusions: Tamsulosin exerts inhibitory effect on neuronal activation in the neuronal voiding centers of OAB. The present results suggest the possibility that tamsulosin is effective therapeutic modality for ameliorating the symptoms of OAB.

참고문헌 (34)

  1. Abrams P, "Describing bladder storage function: overactive bladder syndrome and detrusor overactivity", Urology, 62(5 Suppl 2), pp.28~37 (2003)
  2. Andersson KE, "Pharmacotherapy of the overactive bladder", Discov Med, 8, pp.118~124 (2009)
  3. Chu FM, "Pathophysiology of overactive bladder", Am J Med, 119(3 Suppl 1), pp.3~8 (2006)
  4. Gordon D, "Evaluation of female lower urinary tract symptoms: overview and update", Curr Opin Obstet Gynecol, 13, pp.521~527 (2001)
  5. Rickey LM, "Estrogen-sensitive projections from the medial preoptic area to the dorsal pontine tegmentum, including Barrington’s nucleus, in the rat", Neurourol Urodyn, 27, pp.440~445 (2008)
  6. Blok BF, "Direct projections from the periaqueductal gray to the pontine micturition center (M-region). An anterograde and retrograde tracing study in the cat", Neurosci Lett, 166, pp.93~96 (1994)
  7. de Groat WC, "Mechanisms underlying the recovery of lower urinary tract function following spinal cord injury", Prog Brain Res, 152, pp.59~84 (2006)
  8. Lee TH, "Dependence of rat hippocampal c-Fos expression on intensity and duration of exercise", Life Sci, 72, pp.1421~1436 (2003)
  9. Dinis P, "Intravesical resiniferatoxin decreases spinal c-fos expression and increases bladder volume to reflex micturition in rats with chronic inflamed urinary bladders", BJU Int, 94, pp.153~157 (2004)
  10. Kavia RB, "Functional imaging and the central control of the bladder", J Comp Neurol, 493, pp.27~32 (2005)
  11. Ho MH, "Physiologic role of nitric oxide and nitric oxide synthase in female lower urinary tract", Curr Opin Obstet Gynecol, 16, pp.423~429 (2004)
  12. Pandita RK, "Capsaicin-induced bladder overactivity and nociceptive behaviour in conscious rats: involvement of spinal nitric oxide", J Auton Nerv Syst, 67, pp.184~191 (1997)
  13. Mumtaz FH, "Nitric oxide in the lower urinary tract: physiological and pathological implications", BJU Int, 85, pp.567~578 (2000)
  14. Mamas MA, "Nitric oxide and the lower urinary tract: current concepts, future prospects", Urology, 61, pp.1079~1085 (2003)
  15. Barendrecht MM, "Do alpha1-adrenoceptor antagonists improve lower urinary tract symptoms by reducing bladder outlet resistance?", Neurourol Urodyn, 27, pp.226~230 (2008)
  16. de Groat WC, "Modulation of voiding and storage reflexes by activation of alpha1-adrenoceptors", Eur Urol, 36(Suppl 1), pp.68~73 (1999)
  17. Athanasopoulos A, "Efficacy of the combination of an alpha1-blocker with an anticholinergic agent in the treatment of lower urinary tract symptoms associated with bladder outlet obstruction", Expert Opin Pharmacother, 6, pp.2429~2433 (2005)
  18. Kaplan SA, "Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score", BJU Int, 102, pp.1133~1139 (2008)
  19. Chapple CR, "A comparison of varying alpha-blockers and other pharmacotherapy options for lower urinary tract symptoms", Rev Urol, 7(Suppl 4), pp.S22~S30 (2005)
  20. LaBerge J, "Expression of corticotropin-releasing factor and CRF receptors in micturition pathways after cyclophosphamide-induced cystitis", Am J Physiol Regul Integr Comp Physiol, 291, pp.R692~R703 (2006)
  21. Fowler CJ, "Integrated control of lower urinary tract: clinical perspective", Br J Pharmacol, 147(Suppl 2), pp.S14~S24 (2006)
  22. Blok BF, "Brain control of the lower urinary tract", Scand J Urol Nephrol Suppl, (210), pp.11~15 (2002)
  23. Bon K, "Cyclophosphamide cystitis as a model of visceral pain in rats. A survey of hindbrain structures involved in visceroception and nociception using the expression of c-Fos and Krox-24 proteins", Exp Brain Res, 108, pp.404~416 (1996)
  24. Keay KA, "Convergence of deep somatic and visceral nociceptive information onto a discrete ventrolateral midbrain periaqueductal gray region", Neuroscience, 61, pp.727~732 (1994)
  25. Chung IM, "Effects of acupuncture on abdominal leak point pressure and c-Fos expression in the brain of rats with stress urinary incontinence", NEUROSCIENCE LETTERS, 439, pp.18~23 (2008), ELSEVIER IRELAND LTD
  26. Nazif O, "Neural upregulation in interstitial cystitis", Urology, 69(4 Suppl), pp.24~33 (2007)
  27. Kim HS, "Effects of nitric oxide synthases on detrusor overactivity after removal of bladder outlet obstruction in rats", UROLOGIA INTERNATIONALIS, 81, pp.107~112 (2008), KARGER
  28. Jang J, "Effects of intravesical instillation of cyclooxygenase-2 inhibitor on the expression of inducible nitric oxide synthase and nerve growth factor in cyclophosphamide-induced overactive bladder", BJU Int, 98, pp.435~439 (2006)
  29. Felsen D, "Inducible nitric oxide synthase promotes pathophysiological consequences of experimental bladder outlet obstruction", J Urol, 169, pp.1569~1572 (2003)
  30. Pinggera GM, "alpha-Blockers improve chronic ischaemia of the lower urinary tract in patients with lower urinary tract symptoms", BJU Int, 101, pp.319~324 (2008)
  31. Andersson KE, "Overactive bladder: pharmacological aspects", Scand J Urol Nephrol Suppl, (210), pp.72~81 (2002)
  32. Michel MC, "Efficacy and safety of tamsulosin in the treatment of urological diseases", Expert Opin Pharmacother, 51, pp.151~160 (2004)
  33. Athanasopoulos A, "Combination treatment with an alpha-blocker plus an anticholinergic for bladder outlet obstruction: a prospective, randomized, controlled study", J Urol, 169, pp.2253~2256 (2003)
  34. Jeong MS, "The role of spinal and peripheral alpha1- and alpha2-adrenoceptors on bladder activity induced by bladder distension in anaesthetized rat", BJU Int, 85, pp.925~931 (2000)

관련 논문AI추천

Effects of Combination Treatment of Alpha 1-Adrenergic Receptor Antagonists on Voiding Dysfunction: Study on Target Organs in Overactive Bladder Rats고일규, 김성은, 김창주, 김태형, 문보민, 정경진, 지은상, 진준장, 최현희, 황락경대한배뇨장애요실금학회 · International Neurourology Journal2016 · 제20권 제1호Afferent Pathway-Mediated Effect of α1 Adrenergic Antagonist, Tamsulosin, on the Neurogenic Bladder After Spianl Cord Injury고일규, 김계환, 김성은, 김자영, 한진희대한배뇨장애요실금학회 · International Neurourology Journal2017 · 제21권 제3호Add-on Therapy With the α-Blockers Tamsulosin and Naftopidil Improves Voiding Function by Enhancing Neuronal Activity in Prostatic Hyperplasia Rats고일규, 김상훈, 전정원, 조성태, 진준장, 한진희, 황락경대한배뇨장애요실금학회 · International Neurourology Journal2018 · 제22권 제1호Effects of Spinal and Peripheral Injection of α1A or α1D Adrenoceptor Antagonists on Bladder Activity in Rat Models with or without Bladder Outlet Obstruction강승철, 김재헌, 문두건, 박재영, 배재현, 심강수, 심지성, 이정구대한배뇨장애요실금학회 · International Neurourology Journal2011 · 제15권 제4호Effects of Bladder Function by Early Tamsulosin Treatment in a Spinal Cord Injury Rat Model이강근, 이문영, 정희종, 주민철, 한동엽대한재활의학회 · Annals of Rehabilitation Medicine2014 · 제38권 제4호Characterization on Responsiveness of Excitatory Synaptic Transmissions to α1-Adrenoceptor Blockers in Substantia Gelatinosa Neurons Isolated From Lumbo-Sacral Level in Rat Spinal CordsDaisuke Uta, Megumu Yoshimura, Tsuyoshi Hattori대한배뇨장애요실금학회 · International Neurourology Journal2019 · 제23권 제1호

이 간행물의 다른 논문 (9건)